NEWMindMap Digital has acquired Bluetide.co— deepening our data & agentic-AI stack.Read more →
Home · Customer Stories · US Pharmacy Chain
Healthcare · North America

DSCSA-Compliant Pharmacy Inventory at a US Pharmacy Chain — 1,400 Stores, NASSCOM-Recognised Build

Rx Compliance Stocker rolled out across a 1,400-store US pharmacy chain — DSCSA-compliant traceability with real-time inventory and dispensing controls.

1,400
Stores live with DSCSA traceability
48w
Delivery duration
Managed Cloud
Deployment
4
Accelerators used
Managed CloudUS Pharmacy Chain — 1,400 Stores live with DSCSA traceability
1,400
Stores live
DSCSA
Fully compliant
92%
Stockout-event reduction
$4.8M
Annual inventory carry reduction
In this storyHealthcarePharmacyDSCSAInventoryNASSCOM
01
The challenge

The challenge

The client — a US pharmacy chain operating approximately 1,400 retail pharmacy stores across multiple US states — was approaching the Drug Supply Chain Security Act (DSCSA) enhanced-distribution-security deadline with an inventory-and-traceability platform that the chain's compliance and operations leadership both considered inadequate. The DSCSA requirements (which had been progressively phased in through 2024) required item-level traceability of prescription drugs from the manufacturer to the dispensing pharmacy, with electronic tracing data exchanged at each handoff and retained for a defined period.

The chain's existing pharmacy-management system handled the basic prescription-dispensing workflow but did not provide the DSCSA-required traceability granularity. Layered on top was an inventory-management problem: the chain's stockout-event rate was structurally high (pharmacies routinely running out of high-volume prescriptions and having to redirect patients to other stores or wait for replenishment) and the inventory-carry-cost was structurally also high (chains over-stock as a defense against stockouts in the absence of demand-aware replenishment).

The constraints were significant. DSCSA compliance was a hard regulatory deadline. The chain's pharmacy-management system could not be replaced. The HIPAA compliance posture applied. And the chain's 1,400-store geographic distribution meant any rollout needed to be packaged for predictable per-store deployment by the chain's regional operations teams.

02
The approach

The approach

MindMap deployed Rx Compliance Stocker (Rx) — our pharmacy inventory and DSCSA compliance accelerator — as the unified platform. Rx Compliance Stocker is the NASSCOM-recognised platform from our healthcare portfolio, with DSCSA traceability as a primary use case alongside the demand-aware-replenishment capability the chain also needed. Supporting accelerators included Inventory Optimizer (Io) for the cross-store replenishment optimisation and Demand Forecaster (Df) for the store-level demand forecasting.

Phase one was the DSCSA-traceability build. Each prescription drug item received at a store is now tracked from receipt through to dispense with the full chain-of-custody record. The platform integrates with the chain's existing wholesale-distributor EDI feeds to ingest the inbound DSCSA tracing data, maintains the in-store inventory with item-level lot-and-serial traceability, and produces the outbound DSCSA records on each dispense.

Phase two was the demand-forecasting and replenishment-optimisation build. The chain's stockout problem was driven by inadequate demand forecasting at the store-and-SKU level. Demand Forecaster ingested the chain's historical prescription-volume data, the seasonal and trend patterns, the prescriber-pattern data (specific prescribers driving specific drug volume) and the local market-condition data, and produces per-store-per-SKU demand forecasts on a daily cadence. Inventory Optimizer uses the forecasts to drive replenishment recommendations, with the chain's existing wholesale-distributor relationships handling the actual replenishment.

Phase three was the rollout. The platform was packaged for per-store deployment by the chain's regional operations teams, with a standard two-week per-store deployment cycle that the regional teams could run without central MindMap involvement after the first wave. The 1,400 stores were rolled out over approximately 18 months, with the rollout sequence prioritising the regions with the highest DSCSA-compliance-risk first.

Accelerators in this engagement

The pre-built building blocks

Rather than commission a ground-up build, the engagement leaned on MindMap's pre-built accelerator library — production-tested components that compress what would otherwise be a six-to-nine-month build into weeks.

Rx

Rx Compliance Stocker

DSCSA-traceability and pharmacy inventory platform

Io

Inventory Optimizer

Cross-store replenishment optimisation

Df

Demand Forecaster

Per-store-per-SKU demand forecasting

Dm

DocuMage

Wholesale-shipment document intelligence

03
The architecture

The architecture

The platform runs in the chain's AWS environment, with a central control-plane handling the DSCSA-tracing-data exchange and the demand-forecasting workload, and a per-store edge component handling the in-store inventory-and-dispense workflow with local-network performance optimisation.

DSCSA-traceability is implemented around the EPCIS event-format the DSCSA framework requires. Inbound shipments from the wholesalers arrive with EPCIS-format tracing data; the platform ingests, validates and persists the data with the chain's required retention. The in-store inventory tracking maintains item-level lot-and-serial granularity through to dispense, with the dispense event triggering the outbound EPCIS record that closes the chain of custody.

Demand Forecaster's model is an ensemble: gradient-boosted trees on the per-store-per-SKU classical features (seasonal patterns, day-of-week patterns, trend, holiday effects), a temporal-fusion-transformer for the longer-horizon forecasting that captures cross-SKU and cross-store dynamics, and a per-prescriber sub-model that captures the impact of specific high-volume prescribers' patterns on the store's demand.

Inventory Optimizer's replenishment-recommendation engine combines the demand forecasts with the chain's safety-stock policies, the wholesale-distributor lead-times, the per-store shelf-capacity constraints, and the chain's working-capital targets to produce daily replenishment recommendations per store. The recommendations flow into the chain's existing wholesale-distributor ordering system.

Integration with the chain's pharmacy-management system is via the system's standard inventory-and-dispense interfaces. The platform does not replace the pharmacy-management system; it sits alongside and provides the DSCSA-traceability and demand-aware-replenishment layers the pharmacy-management system does not natively support.

HIPAA compliance is preserved by construction — patient-prescription data is processed only inside the chain's HIPAA-compliant environment, with the platform's audit trail providing the necessary access logging.

The outcomes

The numbers behind the story

1,400
Stores live
DSCSA
Fully compliant
92%
Stockout-event reduction
$4.8M
Annual inventory carry reduction

All 1,400 stores are live on the DSCSA-compliant inventory and traceability platform, ahead of the DSCSA enhanced-security regulatory deadline. The chain's DSCSA-compliance posture has been validated by both the chain's internal compliance team and by an external audit, with no material findings.

Stockout-event rate has dropped by approximately 92% from the pre-platform baseline. The chain's patient-experience metrics on the dispense-availability axis have improved correspondingly, with the previous pattern of patients being redirected to other stores or asked to return later becoming the exception rather than the norm.

Inventory-carry cost has dropped meaningfully — approximately $4.8m annually across the chain — as the demand-aware replenishment has eliminated much of the defensive over-stocking the previous workflow had required. The carry-cost saving is concentrated in the high-velocity SKUs where the forecasting accuracy has been highest.

The chain's pharmacist productivity has improved. The platform's inventory-and-dispense workflow has eliminated much of the inventory-status-checking and replenishment-management work the previous workflow had required pharmacists to perform. Pharmacists' time has been redirected to patient-counselling and clinical-pharmacy work.

The NASSCOM recognition that Rx Compliance Stocker received during the platform's broader market positioning has been a downstream commercial benefit — the chain has cited the platform as a differentiator in its payer-and-employer relationship discussions, with several payer clients specifically referencing the DSCSA-compliance and patient-experience improvements.

DSCSA compliance was a hard deadline we knew we had to meet, and our stockout-and-inventory problem was a chronic operational pain point. MindMap delivered both in a single platform across all fourteen hundred stores ahead of the regulatory deadline, with our pharmacists doing more patient-facing work and our patients experiencing materially better dispense availability.
Chief Operating Officer· US Pharmacy Chain
04
Why MindMap was chosen

Why MindMap was chosen

The chain had evaluated three pharmacy-platform vendors. Two were specialist DSCSA-traceability vendors with no demand-forecasting capability; the third was an integrated pharmacy-management system that would have required replacement of the chain's existing system.

MindMap's Rx Compliance Stocker accelerator brought both the DSCSA-traceability depth and the demand-forecasting-and-replenishment capability in a single integrated platform that augmented the chain's existing pharmacy-management system rather than replacing it. The NASSCOM recognition of the platform was an additional credibility signal for the chain's compliance team.

The willingness to package the platform for per-store deployment by the chain's regional operations teams — rather than requiring central MindMap involvement on every store rollout — was the operational differentiator. The chain's COO felt that the deployment model would scale with the chain's geographic distribution rather than against it.

Want an outcome like this?

Start with a 2-week AI Readiness Sprint. We deliver a prioritised use-case backlog and business case grounded in what's actually buildable with our accelerator library.

Book a walkthrough →Explore Healthcare
Talk to the product team